SPECIAL OFFER : 25% Super Discount For All !
Global Devices for Inhaled Medications Market, By Application (Commercial & Household), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America); Trend Analysis, Competitive Market Share & Forecast, 2020-2026
- Published Date: January 2021
- Report ID: BWC202
- Available Format: PDF
- Page: 178
Report Overview
The global Devices for Inhaled Medications market is expected to reach USD million by 2026, growing at a CAGR of % during the forecast period (2020-2026).
Global Devices for Inhaled Medications Market Size – Industry Trends & Forecast Report 2026
The global Devices for Inhaled Medications market is expected to reach USD million by 2026, growing at a CAGR of % during the forecast period (2020-2026). Devices such as nebulizers have been used in hospitals to deliver drugs more effectively with minimal side effects on patients; inhalers are widely used due to their integration with smart technology; the number of smokers is on the rise and air pollution is rapid On the rise, the lung disease epidemic is the driving force behind the growth of the global inhaler market. The use of smart technology in the production of smart inhalers paves the way for future market growth, and the growth trend of micro-devices contributes to the growth of the market.
Source: BlueWeave Consulting
Global Devices for Inhaled Medications Market Overview:
Lung-based drugs are usually provided to prevent or alleviate asthma attacks and other respiratory diseases. Inhaled drugs or directly inhaled drugs are an important part of the treatment of chronic lung diseases. Various drugs are available in inhaled form. After inhalation, the drug will quickly reach the respiratory tract and be less absorbed into the blood. Many devices deliver drugs directly to the airway. Metered-dose inhalers (MDI), dry powder inhalers, nebulizers, and soft mist inhalers are currently available for a variety of drugs. Combinations of inhaled drugs can be used for many chronic lung diseases, including asthma and COPD.
Global Devices for Inhaled Medications Market Forecast and Trends
Growth Drivers
Rise in prevalence of respiratory diseases
The prevalence of respiratory illnesses (COPD, asthma, emphysema, etc.) is increasing, the demand for first aid drugs during sudden asthma attacks is increasing, and the demand for short-term effective drugs is rapidly increasing. Also, manufacturers will focus on developing advanced portable inhalers, and government awareness programs for COPD and asthma symptoms are expected to drive market growth.
Increasing geriatric population
According to the US Census Bureau, the 2010 census found that there were 40.3 million US residents aged 65 and over, and as of July 1, 2019, there were more than 54 million. According to the United Nations, between 2015 and 2030, that number is estimated to increase by 56% of people aged 60 and over worldwide (from 901 million to more than 1.4 billion). Hence, this is because asthma is a widespread disease among people over 65. Asthma in older people can cause serious health problems if not properly treated. Senior population growth is expected to drive market growth over the forecast period. However, inadequate cost recovery policies and strict regulatory requirements are expected to hamper the growth of asthma and COPD market.
Restraints
High cost of some inhalation devices and treatment.
Over the past few decades, the prevalence and incidence of asthma have increased worldwide due to exposure to a variety of risk factors, mostly related to the environment and lifestyle, as well as genetic background. Also, there are significant differences in cost estimates between studies in the same country. For example, US estimates of the per capita cost of asthma differ by up to five times. Despite different conditions and numbers, many studies indicate that the indirect costs of asthma are at least as high as the direct costs.
Impact of COVID-19 in the industry
In 2020, patients with asthma and COPD appear to have increased their adherence to inhaler drugs during the Covid-19 era, according to a paper published by the Journal of Allergy and Clinical Immunology. Also, the number of inhalers prescribed by general practitioners in England rose in 2020 by 63% between February 2020 and March 2020, according to the National Health Service (NHS). Also, there are shortages of albuterol inhalers in certain areas of the world, such as the United Kingdom and the United States, because hospitals use them mostly for patients with COVID-19. Thus, during the projected era, Covid-19 increased the growth and prospects for COPD and asthma product manufacturers.
Global Devices for Inhaled Medications Market: By Device
Based on segmentation, the global Devices for Inhaled Medications market is categorized into Dry Powder Inhalers, Metered-Dose Inhalers, Nebulizers, and Soft Mist Inhaler. The meter dose inhaler segment held the major market share in 2019, owing to the factors such as inhalation route is the fastest and most effective method of delivering medications to the respiratory system during treatment of COPD and asthma.
Global Devices for Inhaled Medications Market: By Type
Based on segmentation, the global Devices for Inhaled Medications market is categorized into Preventive Inhaler, Reliever inhaler, Long-acting bronchodilators inhaler. Bronchodilators are drugs that relax the bands of the muscles that tighten around your airways. This opens the airway and lets your lungs move more air in and out of it. That allows you to breathe easier. Bronchodilators also help the lungs expel mucus. Open airways mean that mucus can also flow more easily and can be coughed up.
Global Devices for Inhaled Medications Market: By End-use
Among these during the forecast period, the home care segment is projected to report the highest growth rate due to the growing geriatric population, increasing per capita expenditure, and increasing knowledge of respiratory diseases. A Healthcare First organization report found that more than 3.4 million people in the U.S. are receiving qualified home health care services from Medicare because of the growing elderly population and the rising prevalence of chronic health problems in the country.
Global Devices for Inhaled Medications Market: By Application
Based on segmentation, the global Devices for Inhaled Medications market is categorized into Asthma and Chronic Obstructive Pulmonary Disease. Growing geriatric populations with chronic respiratory problems; and lifestyle changes. Also, the launch by pharmaceutical and biotechnology companies of new and innovative pulmonary devices in personalized shapes and sizes, the availability of auto-injectors, and the increase in research and development activities to develop novel oral and nasal drug formulations are some of the other significant factors that are likely to drive the market.
Source: BlueWeave Consulting
Global Devices for Inhaled Medications Market: Regional insights
The global Devices for Inhaled Medications market is segmented into five regions including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounted for the major share of the market size of COPD and asthma devices in 2019 and this trend is expected to continue due to the widespread and early adoption of inhalers & nebulizers and large pools of respiratory disease patients. In addition, the Asia-Pacific region is expected to grow rapidly due to increased spending on healthcare, increased awareness of advanced portable COPD & asthma devices.
Source: BlueWeave Consulting
Recent Development
On July 7, 2020 - Novartis announced that Enerzair Breezhaler (QVM149; indacaterol acetate, glycopyrronium bromide and mometasone furoate [IND/GLY/MF]) has been approved by the European Commission (EC) as a maintenance treatment for asthma in adult patients not sufficiently managed by a long-acting beta2-a gonist (LABA) and high-dose inhaled corticosteroid (ICS) maintenance combination who have encountered one or more inhaled corticosteroids. The first LABA/Long-acting Muscarinic Antagonist (LAMA)/ICS fixed-dose combination available in the EU for these patients is Enerzair Breezhaler once a day.
On Aug 2017 - Propeller Health, a leading digital respiratory medicine solution, today announced the extension of its partnership with GSK in 2015, allowing both companies to plan for and conduct commercial activities using the clip-on sensor and software platform from Propeller for use with the ELLIPTA Inhaler from GSK. Continuing research and development activities will continue to gather data from the Propeller clip-on sensor and software interface used in combination with GSK's asthma and COPD respiratory medicines.
Competitive landscape
Key players for Devices for Inhaled Medications market includes3M Company, Agilent technologies, Aradigm corporation, Astrazeneca plc, Bespak, Beximo pharmaceuticals ltd., Boehringer ingelheimgmbh, Cipla inc., Drive devilbiss healthcare, GE healthcare, Glaxosmithkline, H&T presspart manufacturing ltd, Hovione, Mannkind corporation, Manta devices llc, Midascare, Novartis ag, Omega life sciences, Omron healthcare europeb.v, Philips n.v, Propeller health, Pulmatrix, inc, Savara inc, Spyryx biosciences inc, Teicos pharma ltd, Teijin limited, Teva respiratory llc, Vitalograph, and Other Players.
Scope of the Report
| Attribute | Details |
| Years Considered | Historical data – 2015-2019 |
| Base Year – 2019 | |
| Forecast – 2020 – 2026 | |
| Facts Covered | Revenue in USD Million |
| Market Coverage | China, Japan, South Korea, India, ASEAN, US, Canada, Germany, France, UK, Italy, Brazil, Mexico, Saudi Arabia, UAE & South Africa |
| Product/Service Segmentation | By Device, By type, application End User and region |
| Key Players | Key players for global Devices for Inhaled Medicationsmarket are3M Company, Agilent technologies, Aradigm corporation, Astrazeneca plc, Bespak, Beximo pharmaceuticals ltd., Boehringer ingelheimgmbh, Cipla inc., Drive devilbiss healthcare, GE healthcare, Glaxosmithkline, H&T presspart manufacturing ltd, Hovione, Mannkind corporation, Manta devices llc, Midascare, Novartis ag, Omega life sciences, Omron healthcare europeb.v, Philips n.v, Propeller health, Pulmatrix, inc, Savara inc, Spyryx biosciences inc, Teicos pharma ltd, Teijin limited, Teva respiratory llc, Vitalograph, and Other Players |
By Type
- Preventive Inhaler
- Reliever inhaler
- Long acting bronchodilators inhaler
By Device
- Dry Powder Inhalers
- Metered-Dose Inhalers
- Nebulizers
- Soft Mist Inhaler
By Application
- Asthma
- Chronic Obstructive Pulmonary Disease
By End Use
- Clinic
- Hospital
- Home
By Region:
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Applications
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Primary & Secondary Applications
2.3.2. Secondary Research
2.3.3. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Devices for Inhaled Medications Industry Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Company market share analysis,2018
4.6. Porter’s Five forces analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of New Entrants
4.6.4. Threat of Substitutes
4.6.5. Intensity of Rivalry
5. Global Devices for Inhaled Medications Market Overview
5.1. Market Size & Forecast by Value, 2016-2026
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast 2016-2026
5.2.1. By Device
5.2.1.1. Dry Powder Inhalers
5.2.1.2. Metered-Dose Inhalers
5.2.1.3. Nebulizers
5.2.1.4. Soft Mist Inhaler
5.2.2. By Type
5.2.2.1. Preventive Inhaler
5.2.2.2. Reliever inhaler
5.2.2.3. Long acting bronchodilators inhaler
5.2.3. By Application
5.2.3.1. Asthma
5.2.3.2. Chronic Obstructive Pulmonary Disease
5.2.4. By End User
5.2.4.1. Clinic
5.2.4.2. Hospital
5.2.4.3. Home
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia Pacific
5.2.5.4. Latin America
5.2.5.5. Middle East & Africa
6. North America Devices for Inhaled Medications Market
6.1. Market Size & Forecast by Value, 2016-2026
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast 2016-2026
6.2.1. By Device
6.2.2. By Type
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.2.5.1. U.S
6.2.5.2. Canada
7. Europe Devices for Inhaled Medications Market
7.1. Market Size & Forecast by Value, 2016-2026
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast 2016-2026
7.2.1. By Device
7.2.2. By Type
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. U.K
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Rest of Europe
8. Asia Pacific Devices for Inhaled Medications Market
8.1. Market Size & Forecast by Value, 2016-2026
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast 2016-2026
8.2.1. By Device
8.2.2. By Type
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.2.5.1. China
8.2.5.2. India
8.2.5.3. Japan
8.2.5.4. Rest of Asia Pacific
9. Latin America Devices for Inhaled Medications Market
9.1. Market Size & Forecast by Value, 2016-2026
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast 2016-2026
9.2.1. By Device
9.2.2. By Type
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.2.5.1. Brazil
9.2.5.2. Argentina
9.2.5.3. Rest of Latin America
10. Middle East & Africa Devices for Inhaled MedicationsMarket
10.1. Market Size & Forecast by Value, 2016-2026
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast 2016-2026
10.2.1. By Device
10.2.2. By Type
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.2. UAE
10.2.5.3. South Africa
10.2.5.4. Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Players’ and Their Offerings
11.2. Company Market Ranking/Share Analysis, 2019
11.3. Competitive Benchmarking, By Operating Parameters
12. Impact of COVID-19 across Industry
13. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
13.2. Agilent technologies
13.3. Aradigm corporation
13.4. Astrazeneca plc
13.5. Bespak
13.6. Beximo pharmaceuticals ltd.
13.7. Boehringer ingelheimgmbh
13.8. Cipla Inc.
13.9. Drive devilbiss healthcare
13.10. GE healthcare
13.11. Glaxosmithkline
13.12. H&T presspart manufacturing ltd
13.13. Hovione
13.14. Mannkind corporation
13.15. Manta devices llc
13.16. Midascare
13.17. Novartis ag
13.18. Omega life sciences
13.19. Omron healthcare europeb.v
13.20. Philips n.v
13.21. Propeller health
13.22. Pulmatrix, inc
13.23. Savara inc
13.24. Spyryx biosciences inc
13.25. Teicos pharma ltd
13.26. Teijin limited
13.27. Teva respiratory llc
13.28. Vitalograph
13.29. Other Prominent Player
List of Figures
Fig: Global Devices for Inhaled Medications Segmentation
Fig: Global Devices for Inhaled Medications Market Value Chain Analysis
Fig: Company Market Share Analysis, 2019
Fig: Global Devices for Inhaled Medications Market Size, By Value (USD Million), 2016-2026
Fig: Global Devices for Inhaled Medications Market Share, By Device, By Value, 2016-2026
Fig: Global Devices for Inhaled Medications Market Share, By Type, By Value, 2016-2026
Fig: Global Devices for Inhaled Medications Market Share, By Application, By Value, 2016-2026
Fig: Global Devices for Inhaled Medications Market Share, By End use, By Value, 2016-2026
Fig: Global Devices for Inhaled Medications Market Share, By Region, By Value, 2016-2026
Fig: North America Devices for Inhaled Medications Market Size, By Value (USD Million), 2016-2026
Fig: North America Devices for Inhaled Medications Market Y-o-Y Growth, By Value, 2017-2026
Fig: North America Devices for Inhaled Medications Market Share, By Device, By Value, 2016-2026
Fig: North America Devices for Inhaled Medications Market Share, By Type, By Value, 2016-2026
Fig: North America Devices for Inhaled Medications Market Share, By Application, By Value, 2016-2026
Fig: North America Devices for Inhaled Medications Market Share, By End use, By Value, 2016-2026
Fig: North America Devices for Inhaled Medications Market Share, By Country, By Value, 2016-2026
Fig: Europe Devices for Inhaled Medications Market Size, By Value (USD Million), 2016-2026
Fig: Europe Devices for Inhaled Medications Market Y-o-Y Growth, By Value, 2017-2026
Fig: Europe Devices for Inhaled Medications Market Share, By Device, By Value, 2016-2026
Fig: Europe Devices for Inhaled Medications Market Share, By Type, By Value, 2016-2026
Fig: Europe Devices for Inhaled Medications Market Share, By Application, By Value, 2016-2026
Fig: Europe Devices for Inhaled Medications Market Share, By End use, By Value, 2016-2026
Fig: Europe Devices for Inhaled Medications Market Share, By Country, By Value, 2016-2026
Fig: Asia-Pacific Devices for Inhaled Medications Market Size, By Value (USD Million), 2016-2026
Fig: Asia-Pacific Devices for Inhaled Medications Market Y-o-Y Growth, By Value, 2017-2026
Fig: Asia-Pacific Devices for Inhaled Medications Market Share, By Device, By Value, 2016-2026
Fig: Asia-Pacific Devices for Inhaled Medications Market Share, By Type, By Value, 2016-2026
Fig: Asia-Pacific Devices for Inhaled Medications Market Share, By Application, By Value, 2016-2026
Fig: Asia-Pacific Devices for Inhaled Medications Market Share, By End use, By Value, 2016-2026
Fig: Asia-Pacific Devices for Inhaled Medications Market Share, By Country, By Value, 2016-2026
Fig: Latin America Devices for Inhaled Medications Market Size, By Value (USD Million), 2016-2026
Fig: Latin America Devices for Inhaled Medications Market Y-o-Y Growth, By Value, 2017-2026
Fig: Latin America Devices for Inhaled Medications Market Share, By Device, By Value, 2016-2026
Fig: Latin-America Devices for Inhaled Medications Market Share, By Type, By Value, 2016-2026
Fig: Latin America Devices for Inhaled Medications Market Share, By Application, By Value, 2016-2026
Fig: Latin America Devices for Inhaled Medications Market Share, By End use, By Value, 2016-2026
Fig: Latin America Devices for Inhaled Medications Market Share, By Country, By Value, 2016-2026
Fig: Middle-East & Africa Devices for Inhaled Medications Market Size, By Value (USD Million), 2016-2026
Fig: Middle-East & Africa Devices for Inhaled Medications Market Y-o-Y Growth, By Value, 2017-2026
Fig: Middle-East & Africa Devices for Inhaled Medications Market Share, By Device, By Value, 2016-2026
Fig: Middle-East & Africa Devices for Inhaled Medications Market Share, By Type, By Value, 2016-2026
Fig: Middle-East & Africa Devices for Inhaled Medications Market Share, By Application, By Value, 2016-2026
Fig: Middle-East & Africa Devices for Inhaled Medications Market Share, By End use, By Value, 2016-2026
Fig: Middle East & Africa Devices for Inhaled Medications Market Share, By Country, By Value, 2016-2026
List of Tables:
Table: Global Devices for Inhaled Medications Market Size, By Device, By Value, 2016-2026
Table: Global Devices for Inhaled Medications Market Size, By Type, By Value, 2016-2026
Table: Global Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: Global Devices for Inhaled Medications Market Size, By Region, By Value, 2016-2026
Table: North America Devices for Inhaled Medications Market Size, By Device, By Value, 2016-2026
Table: North America Devices for Inhaled Medications Market Size, By Type, By Value, 2016-2026
Table: North America Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: North America Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: North America Devices for Inhaled Medications Market Size, By Country, By Value, 2016-2026
Table: Europe Devices for Inhaled Medications Market Size, By Device, By Value, 2016-2026
Table: Europe Devices for Inhaled Medications Market Size, By Type, By Value, 2016-2026
Table: Europe Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: Europe Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: Europe Devices for Inhaled Medications Market Size, By Country, By Value, 2016-2026
Table: Asia-Pacific Devices for Inhaled Medications Market Size, By Device, By Value, 2016-2026
Table: Asia-Pacific Devices for Inhaled Medications Market Size, By Type, By Value, 2016-2026
Table: Asia-Pacific Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: Asia-Pacific Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: Asia-Pacific Devices for Inhaled Medications Market Size, By Country, By Value, 2016-2026
Table: Latin America Devices for Inhaled Medications Market Size, By Device, By Value, 2016-2026
Table: Latin America Devices for Inhaled Medications Market Size, By Type, By Value, 2016-2026
Table: Latin America Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: Latin America Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: Latin America Devices for Inhaled Medications Market Size, By Country, By Value, 2016-2026
Table: Middle-East & Africa Devices for Inhaled Medications Market Size, By Device, By Value, 2016-2026
Table: Middle-East Devices for Inhaled Medications Market Size, By Type, By Value, 2016-2026
Table: Middle-East & Africa Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: Middle-East & Africa Devices for Inhaled Medications Market Size, By Application, By Value, 2016-2026
Table: Middle East & Africa Devices for Inhaled Medications Market Size, By Country, By Value, 2016-2026
Table: Samsonite. Financial Analysis
Table: Bluesmart Black Edition Financial Analysis
Table: Horizn Studios GmbH Financial Analysis
Table: TraxPack LLC Financial Analysis
Table: Modobag Financial Analysis
Table: Delsey S.A. Financial Analysis
Table: Planet Traveler USA Financial Analysis
Table: Away Com INC Financial Analysis
Table: Néit Products Ltd Financial Analysis
Table: Trunkster Financial Analysis
*Financial Details Not Be Captured in Case of Unlisted Companies
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
Market Segmentation
By Type
- Preventive Inhaler
- Reliever inhaler
- Long acting bronchodilators inhaler
By Device
- Dry Powder Inhalers
- Metered-Dose Inhalers
- Nebulizers
- Soft Mist Inhaler
By Application
- Asthma
- Chronic Obstructive Pulmonary Disease
By End Use
- Clinic
- Hospital
- Home
By Region:
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Coustom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.